Can CRC tumor microenvironments be sorted into useful subtypes?

Open paper intelligence

Multi-omics CCCRC typing splits colorectal cancers into proliferative (C1), immunosuppressed (C2), immune-excluded (C3), and immunomodulatory (C4) TME classes with different therapy leads.

Source

Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis

Wu X, Yan H, Qiu M, et al. · eLife · 2023

doi.org/10.7554/elife.86032 Read the full paper ↗37 citationscc by

Study at a glance

Design: Computational / modelling — Integrative multi-omics + AI spatial WSI analysis defining CCCRC TME subtypes
N: N=1471 · 1471 CRC patients in CRC-AFFY cohort heatmap; 725 in CRC-RNAseq cohort
Population: Colorectal cancer bulk/multi-omics cohorts with TME signature profiling
Outcome: Four CCCRC TME subtypes with distinct therapy/prognosis implications

Structured fields used in claim comparison tables when every cited study has a complete layer.

What they did

Built a 61-signature TME panel, integrated multi-omics CRC cohorts, and used AI-enabled spatial whole-slide analysis to define CCCRC subtypes, then linked subtypes to histology, molecular features, treatment sensitivity, prognosis, and a simple gene classifier.

What they found

C1 is proliferative/low immunogenicity (chemo + cetuximab candidate); C2 is immunosuppressed/terminally exhausted (chemo + bevacizumab candidate); C3 is stromal/immune-excluded (WNT inhibitor WIKI4 sensitivity); C4 is immunomodulatory (immune checkpoint blockade candidate).

The limits

What it doesn't show

Subtype–therapy matches are hypothesis-generating from observational/computational data, not randomized treatment trials.

Key terms

TME: Tumor microenvironment of immune, stromal, and metabolic compartments.
CCCRC: Comprehensive characterization of CRC TME subtype system in this paper.
Immune-excluded: Stromal upregulation with poor T-cell infiltration into the tumor core.
Immunomodulatory: TME with upregulated anti-tumor immune components.
Gene classifier: Simple gene set used to assign CCCRC subtype.

Flashcards

1 / 9

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

How many CCCRC subtypes were defined?

Common questions

How many subtypes?

Four CCCRC subtypes (C1–C4).

C4 therapy angle?

Potential immune checkpoint blockade candidate.

TME panel size?

61 TME-related signatures.

Large AFFY cohort N?

1471 CRC patients.